Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42

被引:130
作者
Butterfield, DA [1 ]
Kanski, J
机构
[1] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
基金
美国国家卫生研究院;
关键词
amyloid; methionine; oxidative stress;
D O I
10.1016/S0196-9781(02)00066-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid beta-peptide 1-42 [Abeta(1-42)] is central to the pathogenesis of Alzheimer's disease (AD), and the AD brain is under intense oxidative stress. Our laboratory combined these two aspects of AD into the Abeta-associated free radical oxidative stress model for neurodegeneration in AD brain. Abeta(1-42) caused protein oxidation, lipid peroxidation, reactive oxygen species formation, and cell death in neuronal and synaptosomal systems, all of which could be inhibited by free radical antioxidants. Recent studies have been directed at discerning molecular mechanisms by which Abeta(1-42)-associated free radical oxidative stress and neurotoxicity arise. The single methionine located in residue 35 of Abeta(1-42) is critical for these properties. This review presents the evidence supporting the role of methionine in Abeta(1-42)-associated free radical oxidative stress and neurotoxicity. This work is of obvious relevance to AD and provides a coupling between the centrality of Abeta(1-42) in the pathogenesis of AD and the oxidative stress under which the AD brain exists. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1299 / 1309
页数:11
相关论文
共 92 条
[1]   Oxidative modification of creatine kinase BB in Alzheimer's disease brain [J].
Aksenov, M ;
Aksenova, M ;
Butterfield, DA ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2520-2527
[2]  
Aksenov MY, 1996, J NEUROCHEM, V66, P2050
[3]   Protein oxidation in the brain in Alzheimer's disease [J].
Aksenov, MY ;
Aksenova, MV ;
Butterfield, DA ;
Geddes, JW ;
Markesbery, WR .
NEUROSCIENCE, 2001, 103 (02) :373-383
[4]  
AKSENOV MY, 1995, J NEUROCHEM, V65, P1899
[5]   Oxidative modification of glutamine synthetase by amyloid beta peptide [J].
Aksenov, MY ;
Aksenova, MV ;
Carney, JM ;
Butterfield, DA .
FREE RADICAL RESEARCH, 1997, 27 (03) :267-281
[6]  
Albers DS, 2000, J NEURAL TRANSM-SUPP, P133
[7]  
[Anonymous], 1974, Critical Stability Constants
[8]  
Avdulov NA, 1997, J NEUROCHEM, V68, P2086
[9]  
Bruce-Keller AJ, 1998, J NEUROCHEM, V70, P31
[10]  
Bush AI, 1999, NEUROBIOL AGING, V20, P335